Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

This study is about comparing two treatments for adults who have asthma that isn't well-managed. One treatment uses a mix of medicines called FF/UMEC/VI, and the other uses inhaled corticosteroids (ICS) with long-acting beta-2 agonists (LABA), which help open airways.

To join, you must have asthma as per the Global Initiative for Asthma (GINA) guidelines for at least 3 months and be able to fill out questionnaires. People who recently had very bad asthma attacks, are pregnant, or have conditions like chronic obstructive pulmonary disease (COPD) can't participate. Also, if you're using certain medications, you might not be eligible.

• Study Length: Not specified, but it requires prior asthma diagnosis and may involve multiple visits.
• Medications: Testing new inhaler options vs. usual care.
• Risks: Must not have severe recent asthma attacks or specific medication use.